Unfortunate but entirely understandable issues seem to have...

Unfortunate but entirely understandable issues seem to have delayed both human clinical trials.

I find this disappointing, but I take comfort in the reported fact that so far, despite slow recruitment, the trials have shown the Novosorb materials performing positively as expected.

The progress with composite cultured skin is also very encouraging. Hopefully human trials of this important new development can start relatively soon, perhaps in 2013 assuming a successful conclusion of the present BYM trial and successful conclusion of any necessary laboratory and animal studies.

I'm not sure if this announcement will light a fire under the share price; probably not, but it does get us one day closer to the eventual announcement that will.